European regulators endorse Sanofi's simpler sleeping sickness pill for use in Congo and other African nations

European regulators endorsed Sanofi's new sleeping sickness pill, acoziborole, a crucial step toward eliminating the disease. The one-time, three-pill dose is simpler and more accessible than current treatments, potentially accelerating elimination efforts in Congo and other African nations. Sleeping sickness, spread by tsetse flies, is a disease of poverty with cases significantly declining in recent years.